Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3456)
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
44,050
Price
$115.69
Total Value
$5.10M
Shares Held After
669,904
% of Holdings
6.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
24,105
Price
$114.96
Total Value
$2.77M
Shares Held After
713,954
% of Holdings
3.3%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
6,626
Price
$113.98
Total Value
$755.20K
Shares Held After
738,059
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,883
Price
$112.80
Total Value
$212.41K
Shares Held After
744,685
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
3,389
Price
$114.29
Total Value
$387.33K
Shares Held After
47,179
% of Holdings
6.7%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
90,000
Price
$8.03
Total Value
$722.51K
Shares Held After
1,691,126
% of Holdings
5.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
625
Price
$77.21
Total Value
$48.26K
Shares Held After
42,044
% of Holdings
1.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,000
Price
$76.39
Total Value
$76.39K
Shares Held After
42,669
% of Holdings
2.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
2,501
Price
$16.24
Total Value
$40.61K
Shares Held After
135,202
% of Holdings
1.8%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
5,852
Price
$15.67
Total Value
$91.68K
Shares Held After
137,703
% of Holdings
4.1%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$84.92
Total Value
$636.90K
Shares Held After
377,830
% of Holdings
1.9%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
1,112
Price
$87.79
Total Value
$97.62K
Shares Held After
63,221
% of Holdings
1.7%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
69,648
Price
$39.41
Total Value
$2.74M
Shares Held After
24,555
% of Holdings
73.9%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
130,352
Price
$39.41
Total Value
$5.14M
Shares Held After
94,203
% of Holdings
58.0%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$85.80
Total Value
$1.29M
Shares Held After
58,555
% of Holdings
20.4%
ORAMED PHARMACEUTICALS INC. (ORMP)
Gabay Avraham — Chief Financial Officer
Shares
73,360
Price
$4.51
Total Value
$330.74K
Shares Held After
671,785
% of Holdings
9.8%
ORAMED PHARMACEUTICALS INC. (ORMP)
Hexter Joshua — COO & CBO
Shares
137,000
Price
$4.46
Total Value
$611.43K
Shares Held After
1,023,384
% of Holdings
11.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,597
Price
$30.44
Total Value
$48.61K
Shares Held After
287,171
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
30,311
Price
$29.95
Total Value
$907.92K
Shares Held After
288,768
% of Holdings
9.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$29.98
Total Value
$77.73K
Shares Held After
23,337
% of Holdings
10.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
1,200
Price
$30.34
Total Value
$36.40K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
13,409
Price
$29.86
Total Value
$400.46K
Shares Held After
1,200
% of Holdings
91.8%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
240,000
Price
$0.04
Total Value
$10.34K
Shares Held After
94,124,319
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,127
Price
$13.02
Total Value
$27.69K
Shares Held After
90,180
% of Holdings
2.3%
Oruka Therapeutics, Inc. (ORKA)
Fairmount Funds Management LLC — Director
Shares
3,553,410
Price
$84.43
Total Value
$300.01M
Shares Held After
1,131,954
% of Holdings
75.8%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
600
Price
$24.22
Total Value
$14.53K
Shares Held After
46,688
% of Holdings
1.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,400
Price
$23.40
Total Value
$102.96K
Shares Held After
46,088
% of Holdings
9.5%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
36,725
Price
$12.86
Total Value
$472.28K
Shares Held After
213,009
% of Holdings
14.7%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
37,799
Price
$17.00
Total Value
$642.63K
Shares Held After
9,174,453
% of Holdings
0.4%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
500
Price
$95.47
Total Value
$47.74K
Shares Held After
236,384
% of Holdings
0.2%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,263
Price
$94.75
Total Value
$214.41K
Shares Held After
236,884
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,237
Price
$93.85
Total Value
$209.93K
Shares Held After
239,147
% of Holdings
0.9%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
49,666
Price
$240.25
Total Value
$11.93M
Shares Held After
7,229
% of Holdings
87.3%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
4,666
Price
$4.48
Total Value
$20.90K
Shares Held After
137,482
% of Holdings
3.3%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
25,947
Price
$4.48
Total Value
$116.24K
Shares Held After
377,817
% of Holdings
6.4%
Lexeo Therapeutics, Inc. (LXEO)
Bhalla Narinder Pal — Chief Medical Officer
Shares
22,306
Price
$4.42
Total Value
$98.59K
Shares Held After
82,194
% of Holdings
21.3%
Lexeo Therapeutics, Inc. (LXEO)
Tamayo Louis Edward — Chief Financial Officer
Shares
4,641
Price
$4.49
Total Value
$20.84K
Shares Held After
97,024
% of Holdings
4.6%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
700
Price
$52.13
Total Value
$36.49K
Shares Held After
73,389
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
8,300
Price
$51.46
Total Value
$427.13K
Shares Held After
74,089
% of Holdings
10.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
171,429
Price
$5.53
Total Value
$948.00K
Shares Held After
354,535
% of Holdings
32.6%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
3,057
Price
$1.93
Total Value
$5.90K
Shares Held After
15,492
% of Holdings
19.7%
Absci Corp (ABSI)
Szela Mary T — Director
Shares
12,900
Price
$11.54
Total Value
$148.87K
Shares Held After
21,300
% of Holdings
60.6%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,438
Price
$15.02
Total Value
$36.61K
Shares Held After
0
% of Holdings
100.0%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
2,438
% of Holdings
50.0%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
373
Price
$34.73
Total Value
$12.95K
Shares Held After
102,363
% of Holdings
0.4%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
6,566
Price
$14.00
Total Value
$91.92K
Shares Held After
8,617
% of Holdings
43.2%
Legend Biotech Corp (LEGN)
Casey Patrick John — Director
Shares
6,000
Price
$14.80
Total Value
$88.80K
Shares Held After
48,604
% of Holdings
11.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
4,654
Price
$20.00
Total Value
$93.08K
Shares Held After
51,776
% of Holdings
8.2%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
101,050
Price
$21.12
Total Value
$2.13M
Shares Held After
308,504
% of Holdings
24.7%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
23,365
Price
$7.08
Total Value
$165.42K
Shares Held After
86,380
% of Holdings
21.3%
Showing 901–950 of 3456 transactions (page 19 of 70)